Cost-effectiveness of influenza vaccination in high-risk children in Argentina

被引:30
|
作者
Dayan, GH
Nguyen, VH
Debbag, R
Gómez, R
Wood, SC
机构
[1] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina
[2] Aventis Pasteur, Buenos Aires, DF, Argentina
[3] Biogen Europe, Paris, France
关键词
influenza; vaccination; cost-effectiveness;
D O I
10.1016/S0264-410X(01)00160-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: our study aimed to evaluate the cost-effectiveness of influenza vaccination in high-risk children in Argentina. Methods: a decision analysis model was performed, using data from published and unpublished sources. to compare two strategies - to vaccinate or not to vaccinate. We simulated the expected consequences of vaccination on direct medical costs, related to disease management and indirect costs, related to lost parental working days (absenteeism). Results: Using base-case assumptions vaccination of high-risk children aged 6 months to 15 years old, in Argentina (estimated cohort of 1184748) would prevent 207331 cases of influenza, resulting in a reduction of 58052 days of hospitalization and 207331 outpatient visits. Vaccination would lead to net savings of US$ 11894870 per vaccinated cohort (US$ 10.04 per vaccinated child). Conclusion: our economic analysis shows that in Argentina, routine vaccination of high-risk children against influenza would be cost saving for society. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4204 / 4213
页数:10
相关论文
共 50 条
  • [31] Cost-effectiveness of universal influenza vaccination in a pregnant population
    Roberts, Scott
    Hollier, Lisa M.
    Sheffield, Jeanne
    Laibl, Vanessa
    Wendel, George D., Jr.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (06): : 1323 - 1329
  • [32] Influenza vaccination in children with high-risk chronic diseases YY
    Hatziagorou, Elpis
    Argyropoulou, Evangelia
    Soldatou, Alexandra
    Tsanakas, John
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Influenza vaccination of high-risk children - What the providers say
    Rickert, D
    Santoli, J
    Shefer, A
    Myrick, A
    Yusuf, H
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 30 (02) : 111 - 118
  • [34] Influenza Vaccination Rates of Children in Households with High-Risk Adults
    Chi, Ru-Chien
    Reiber, Gayle E.
    Lipsky, Benjamin A.
    Boyko, Edward J.
    Neuzil, Kathleen M.
    PUBLIC HEALTH REPORTS, 2010, 125 (02) : 192 - 198
  • [35] Cost-effectiveness of bisphosphonate therapy in high-risk osteoporotic women
    Grima, D
    Burge, RT
    Becker, D
    Tosteson, ANA
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S82 - S83
  • [36] Cost-effectiveness of antifungal strategies in high-risk neutropenic patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2007, 110 (11) : 153B - 153B
  • [37] SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF PALIVIZUMAB IN HIGH-RISK PATIENTS
    Paladio Duran, N.
    Garcia-Altes, A.
    Pons Rafols, J. M.
    Tebe Cordomi, C.
    VALUE IN HEALTH, 2009, 12 (07) : A432 - A432
  • [38] Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients
    Schwarzinger, Michael
    Baillot, Sylvain
    Beauchamp, Celine
    Maury, Sebastien
    Pautas, Cecile
    Vekhoff, Anne
    Farhat, Hassan
    Suarez, Felipe
    Hemery, Francois
    Kuentz, Mathieu
    Cordonnier, Catherine
    BLOOD, 2008, 112 (11) : 475 - 475
  • [39] Safety and cost-effectiveness of MIDCABG in high-risk CABG patients
    Del Rizzo, DF
    Boyd, WD
    Novick, RJ
    McKenzie, FN
    Desai, ND
    Menkis, AH
    ANNALS OF THORACIC SURGERY, 1998, 66 (03): : 1002 - 1007
  • [40] COST-EFFECTIVENESS OF ENVIRONMENTAL SURVEILLANCE IN A HIGH-RISK NEONATAL UNIT
    ELDER, D
    RICHARDSON, H
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1977, 68 (04): : 338 - 339